Houston-based Hatch Pitch will host two competitions in spring of 2020 — one marks the return of the competition to the Bayou City. Photo courtesy of Hatch Pitch

For eight years, Greg Wright has been organizing a SXSW pitch competition in Austin for startups from around the world that are using technology to improve life. In 2020, Wright is bringing Houston-based Hatch Pitch back into the Bayou City — a goal he's had for a while — for a new cybersecurity-focused event.

"Many people know us as being associated with Austin and SXSW, but not many people know us as being based in Houston," Wright tells InnovationMap. "There's been a big push to bring Hatch back to Houston, and what we've been struggling with is finding the right vehicle."

After Hatch Pitch Summit returns to Austin for its ninth year on March 16, Cyber Hatch will be hosted by the annual Houston Cyber Summit on April 28. Applications for both competitions are open and available online.

"We are excited to bring Hatch Pitch to Houston for the first time since 2013," says Wright, founder of the competition, in a press release. "The gathering of all this expertise at Houston Cyber Summit is the perfect place to foster innovation. It's an opportunity to meet and exchange ideas between startups, investors, customers, partners, leaders and change-makers."

The Houston Cyber Summit, which is going into its fourth year, will introduce a new innovation track to the event, which attracts cybersecurity experts from across industries. The pitch competition will shine a spotlight on early-stage companies creating safety and security online.

"The Houston Cyber Summit annually brings together a highly qualified, trusted network of business, government and academic leaders from across the Greater Houston region and beyond," says Umesh Verma, founder of Houston Cyber Summit and CEO of BLUE LANCE. "Partnering with industry leader Hatch Pitch, adds a new and exciting dimension to the cybersecurity and privacy landscape of our region and creates a new set of high paying jobs."

For each of the two spring competitions, four finalists will be selecting from hundreds of applications from companies around the world. All eight finalists will have access to mentors before pitching at the live events where they will field questions from the panel of judges. Similar to years prior, the pitches will be live streamed.

Over the past near decade, Hatch Pitch finalists have gone on to raise over $360 million and seen 11 successful exits. Recently Houston-based Braincheck, which won the competition in 2016, raised an $8M series A round earlier this year.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.